PT Kalbe Farma Tbk(ID:KLBF)
Rp770.00+20.00 (+2.67%)
ID:KLBF
PT Kalbe Farma Tbk financials statements
Rp770.00
At close:+20.00 (+2.67%)
PT Kalbe Farma Tbk (KLBF) Ratios
PT Kalbe Farma Tbk Ratios
ID:KLBF's free cash flow for Q3 2026 was Rp1.18T. For the 2026 fiscal year, ID:KLBF's free cash flow was decreased by Rp-212.40B and operating cash flow was Rp1.39T. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.47 | 4.11 | 4.91 | 3.77 | 4.45 |
| Quick Ratio | 2.16 | 2.55 | 2.81 | 2.19 | 3.01 |
| Cash Ratio | 0.81 | 1.13 | 1.00 | 0.89 | 1.76 |
| Solvency Ratio | 0.75 | 0.74 | 0.89 | 0.80 | 0.88 |
| Operating Cash Flow Ratio | 0.61 | 1.14 | 0.90 | 0.85 | 0.80 |
| Short-Term Operating Cash Flow Coverage | 29.11 | 14.86 | 10.45 | 4.55 | 40.37 |
| Net Current Asset Value | Rp 12.54T | Rp 12.35T | Rp 11.98T | Rp 11.57T | Rp 11.31T |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.02 | 0.02 | 0.04 | 0.02 |
| Debt-to-Equity Ratio | 0.01 | 0.02 | 0.03 | 0.06 | 0.03 |
| Debt-to-Capital Ratio | 0.01 | 0.02 | 0.03 | 0.05 | 0.03 |
| Long-Term Debt-to-Capital Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
| Financial Leverage Ratio | 1.32 | 1.29 | 1.26 | 1.34 | 1.31 |
| Debt Service Coverage Ratio | 31.06 | 9.62 | 9.65 | 4.87 | 34.32 |
| Interest Coverage Ratio | 128.95 | 72.22 | 38.18 | 108.97 | 91.47 |
| Debt to Market Cap | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
| Interest Debt Per Share | 7.30 | 13.34 | 15.43 | 25.99 | 14.33 |
| Net Debt to EBITDA | -0.72 | -0.90 | -0.59 | -0.53 | -1.15 |
| Profitability Margins | |||||
| Gross Profit Margin | 39.79% | 39.71% | 37.94% | 40.45% | 42.97% |
| EBIT Margin | 13.63% | 13.10% | 12.12% | 15.60% | 16.00% |
| EBITDA Margin | 15.90% | 14.14% | 14.56% | 18.13% | 18.56% |
| Operating Profit Margin | 12.87% | 12.47% | 11.92% | 15.53% | 15.84% |
| Pretax Profit Margin | 13.53% | 12.93% | 11.84% | 15.41% | 15.78% |
| Net Profit Margin | 10.38% | 9.93% | 9.09% | 11.69% | 12.12% |
| Continuous Operations Profit Margin | 10.60% | 9.95% | 9.12% | 11.92% | 12.31% |
| Net Income Per EBT | 76.70% | 76.81% | 76.72% | 75.85% | 76.84% |
| EBT Per EBIT | 105.14% | 103.72% | 99.32% | 99.26% | 99.58% |
| Return on Assets (ROA) | 11.94% | 11.01% | 10.23% | 12.42% | 12.40% |
| Return on Equity (ROE) | 15.72% | 14.22% | 12.92% | 16.59% | 16.26% |
| Return on Capital Employed (ROCE) | 17.92% | 16.11% | 15.25% | 19.69% | 18.80% |
| Return on Invested Capital (ROIC) | 13.97% | 12.23% | 11.60% | 14.69% | 14.60% |
| Return on Tangible Assets | 12.91% | 11.97% | 10.96% | 13.15% | 12.99% |
| Earnings Yield | 6.68% | 4.59% | 3.79% | 2.75% | 4.23% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.99 | 6.51 | 6.55 | 6.04 | 7.41 |
| Payables Turnover | 8.85 | 10.40 | 11.18 | 8.63 | 8.98 |
| Inventory Turnover | 3.04 | 3.03 | 2.78 | 2.45 | 2.94 |
| Fixed Asset Turnover | 4.04 | 3.73 | 3.58 | 3.47 | 3.16 |
| Asset Turnover | 1.15 | 1.11 | 1.13 | 1.06 | 1.02 |
| Working Capital Turnover Ratio | 2.70 | 2.54 | 2.44 | 2.37 | 2.38 |
| Cash Conversion Cycle | 139.56 | 141.61 | 154.29 | 166.97 | 132.61 |
| Days of Sales Outstanding | 60.93 | 56.08 | 55.76 | 60.40 | 49.27 |
| Days of Inventory Outstanding | 119.87 | 120.64 | 131.18 | 148.87 | 123.98 |
| Days of Payables Outstanding | 41.23 | 35.11 | 32.66 | 42.30 | 40.64 |
| Operating Cycle | 180.80 | 176.72 | 186.95 | 209.27 | 173.25 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 71.84 | 103.69 | 62.86 | 81.04 | 60.29 |
| Free Cash Flow Per Share | 54.05 | 76.60 | 37.37 | 62.33 | 38.94 |
| Dividend Paid and CapEx Coverage Ratio | 1.34 | 1.78 | 0.99 | 1.51 | 1.22 |
| Capital Expenditure Coverage Ratio | 4.04 | 3.83 | 2.47 | 4.33 | 2.82 |
| Operating Cash Flow Coverage Ratio | 11.00 | 8.56 | 4.70 | 3.23 | 4.51 |
| Operating Cash Flow to Sales Ratio | 0.09 | 0.15 | 0.10 | 0.13 | 0.11 |
| Free Cash Flow Yield | 4.49% | 5.01% | 2.37% | 2.36% | 2.42% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 14.97 | 21.79 | 26.38 | 36.39 | 23.64 |
| Price-to-Sales (P/S) Ratio | 1.55 | 2.16 | 2.40 | 4.25 | 2.87 |
| Price-to-Book (P/B) Ratio | 2.35 | 3.10 | 3.41 | 6.04 | 3.84 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 22.29 | 19.98 | 42.23 | 42.45 | 41.24 |
| Price-to-Operating Cash Flow Ratio | 16.77 | 14.76 | 25.10 | 32.65 | 26.64 |
| Price-to-Earnings Growth (PEG) Ratio | 1.01 | 1.25 | -1.49 | 5.16 | 1.43 |
| Enterprise Value Multiple | 9.05 | 14.40 | 15.88 | 22.93 | 14.30 |
| Enterprise Value | 50.82T | 66.45T | 70.38T | 120.30T | 69.68T |
| EV to EBITDA | 9.05 | 14.40 | 15.88 | 22.93 | 14.30 |
| EV to Sales | 1.44 | 2.04 | 2.31 | 4.16 | 2.65 |
| EV to Free Cash Flow | 20.65 | 18.80 | 40.72 | 41.49 | 38.18 |
| EV to Operating Cash Flow | 15.54 | 13.89 | 24.21 | 31.91 | 24.66 |
| Tangible Book Value Per Share | 492.32 | 481.89 | 460.77 | 442.20 | 428.99 |
| Shareholders’ Equity Per Share | 512.09 | 493.81 | 463.05 | 438.24 | 417.71 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.22 | 0.23 | 0.23 | 0.23 | 0.22 |
| Revenue Per Share | 775.95 | 707.01 | 658.28 | 622.01 | 560.26 |
| Net Income Per Share | 80.51 | 70.22 | 59.81 | 72.71 | 67.92 |
| Tax Burden | 0.77 | 0.77 | 0.77 | 0.76 | 0.77 |
| Interest Burden | 0.99 | 0.99 | 0.98 | 0.99 | 0.99 |
| Research & Development to Revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
| SG&A to Revenue | 0.15 | 0.15 | 0.02 | 0.02 | 0.02 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.89 | 23816.40 | 1.05 | 1.11 | 0.89 |
Currency in IDR
